Idexx Laboratories Inc(IDXX)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $513.02 – $769.98
- YTD
- -14.46%
- IV Rank (30D)
- 22.24
- Straddle Price
- $66.40
- P/C Vol Ratio
- 1.40
- Market Cap
- $45.4B
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.58% |
| Beta vs SPY | 1.00 |
| Cost of Equity (CAPM) | 9.86% (VRP-adj) |
| WACC | 9.87% |
| Volatility Risk Premium | +8.6pp (IV − HV30), ERP adj +28bps |
| Effective Tax Rate | 20.0% |
| Rev. Growth (YoY, DCF input) | +2.8% |
| DCF Horizon | 12 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.03 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $1.1B |
| Return on Equity (TTM) | 70.4% |
| Book / Price | 3.3% |
| Gross Margin (TTM) | 62.1% |
| FCF Margin (TTM) | 24.4% |
| Debt / Equity | 0.19 |
| Quality Score | 5/6 — high quality (12y DCF) |
| Market-Implied Growth | +20.5% (reverse-DCF on current price) |
| SMA 50 | $555.03 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $552.92 |
| Bollinger Width / SMA20 | 1.6% (drives anchor stability) |
| Net Debt | $0.1B |
| Market Cap | $46B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $189.42 | 19% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $476.52 | 9% | median 34.1× · 8 peers |
| Peer EV/EBITDA | $362.26 | 9% | median 18.4× · 8 peers |
| Peer P/B | $137.36 | 2% | median 7.1× · 8 peers |
| Peer P/S | $215.80 | 6% | median 3.8× · 8 peers |
| Market Anchor (SMA50) | $555.03 | 38% | stability 100% (BB-width) |
| Options Expected (B-L 30d) | $498.96 | 19% | 30 strikes · skew +0.52 |
- Industry (SIC)
- IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES (2835)
- Exchange
- XNAS
- Market Cap
- $45.4B
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +2.67% | 23 |
| Feb | +1.51% | 23 |
| Mar | +1.21% | 23 |
| Apr | +2.52% | 23 |
| May | +1.03% | 23 |
| Jun | +2.81% | 23 |
| Jul | +4.40% | 23 |
| Aug | +1.76% | 22 |
| Sep | -0.91% | 23 |
| Oct | -0.37% | 23 |
| Nov | +1.91% | 23 |
| Dec | +2.20% | 23 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-08-06 | Pre-Market | 8.25% | 2.62% | 0.32x | Within |
| 2024-10-31 | Pre-Market | 7.70% | 9.87% | 1.28x | Exceeded |
| 2025-02-03 | Pre-Market | 8.66% | 11.28% | 1.30x | Exceeded |
| 2025-05-01 | Pre-Market | 7.68% | 9.23% | 1.20x | Exceeded |
| 2025-08-04 | Pre-Market | 7.92% | 27.56% | 3.48x | Exceeded |
| 2025-11-03 | Pre-Market | 10.02% | 14.58% | 1.46x | Exceeded |
| 2026-02-02 | Pre-Market | 10.55% | 4.98% | 0.47x | Within |
| 2026-05-05 | Pre-Market | 9.56% | 0.21% | 0.02x | Within |
- IV Rank (30D)
- 22.24
- IV Rank (7D)
- 100
- Avg IV
- 45.2%
- Straddle (30D)
- $66.40
- Straddle (7D)
- $11.28
- P/C Volume
- 1.40
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
- Beta (1Y vs SPY)
- 1.22
- Correlation (SPY)
- 35.8%
- R²
- 0.13
- Ann. Volatility
- 43.0%
- SPY Volatility
- 12.6%
High volatility - stock moves more than market
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $25.57M | 33.79% | 2026-03-31 |
| 2 | MILLENNIUM MANAGEMENT LLC Custodian | $18.82M | 24.88% | 2026-03-31 |
| 3 | CITADEL ADVISORS LLC Custodian | $13.32M | 17.60% | 2026-03-31 |
| 4 | WOLVERINE TRADING, LLC Custodian | $6.56M | 8.67% | 2025-09-30 |
| 5 | JANE STREET GROUP, LLC Custodian | $5.45M | 7.20% | 2026-03-31 |
| 6 | Twin Tree Management, LP | $2.47M | 3.27% | 2026-03-31 |
| 7 | HSBC HOLDINGS PLC Custodian | $1.97M | 2.60% | 2026-03-31 |
| 8 | Allianz Asset Management GmbH | $899.02K | 1.19% | 2026-03-31 |
| 9 | TUDOR INVESTMENT CORP ET AL | $224.76K | 0.30% | 2026-03-31 |
| 10 | Walleye Capital LLC | $168.57K | 0.22% | 2026-03-31 |
| 11 | Capula Management Ltd | $112.38K | 0.15% | 2026-03-31 |
| 12 | PEAK6 LLC | $112.38K | 0.15% | 2026-03-31 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $14.33M | 29.66% | 2026-03-31 |
| 2 | CITADEL ADVISORS LLC Custodian | $9.89M | 20.47% | 2026-03-31 |
| 3 | PEAK6 LLC | $5.68M | 11.75% | 2026-03-31 |
| 4 | JANE STREET GROUP, LLC Custodian | $5.39M | 11.16% | 2026-03-31 |
| 5 | BRANT POINT INVESTMENT MANAGEMENT LLC | $3.26M | 6.75% | 2026-03-31 |
| 6 | WOLVERINE TRADING, LLC Custodian | $3.03M | 6.26% | 2025-09-30 |
| 7 | MILLENNIUM MANAGEMENT LLC Custodian | $1.74M | 3.61% | 2026-03-31 |
| 8 | Allianz Asset Management GmbH | $1.40M | 2.91% | 2026-03-31 |
| 9 | Old Port Advisors | $1.12M | 2.33% | 2026-03-31 |
| 10 | DGS Capital Management, LLC | $1.12M | 2.33% | 2026-03-31 |
| 11 | BNP PARIBAS FINANCIAL MARKETS Custodian | $449.51K | 0.93% | 2026-03-31 |
| 12 | Walleye Trading LLC | $449.51K | 0.93% | 2026-03-31 |
| 13 | Capula Management Ltd | $168.57K | 0.35% | 2026-03-31 |
| 14 | Walleye Capital LLC | $168.57K | 0.35% | 2026-03-31 |
| 15 | Twin Tree Management, LP | $112.38K | 0.23% | 2026-03-31 |
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-06-02 | GEORGE FENNELL | Executive Vice President | Mixed | +355 | $566.79 | -$161.0K | EDGAR |
| 2026-05-14 | Irene Chang Britt | Director | Grant (A) | +759 RSU | — | EDGAR | |
| 2026-05-14 | Bruce L. Claflin | Director | Grant (A) | +759 RSU | — | EDGAR | |
| 2026-05-14 | STUART ESSIG | Director | Grant (A) | +759 RSU | — | EDGAR | |
| 2026-05-14 | JOSEPH L HOOLEY | Director | Grant (A) | +759 opt | — | EDGAR | |
| 2026-05-14 | DANIEL M JUNIUS | Director | Grant (A) | +759 RSU | — | EDGAR | |
| 2026-05-14 | Lawrence D Kingsley | Director | Grant (A) | +1,002 opt | — | EDGAR | |
| 2026-05-14 | Karen Peacock | Director | Grant (A) | +759 RSU | — | EDGAR | |
| 2026-05-14 | SAM SAMAD | Director | Grant (A) | +759 opt | — | EDGAR | |
| 2026-05-14 | Sophie V. Vandebroek | Director | Grant (A) | +759 opt | — | EDGAR | |
| 2026-05-11 | JOSEPH L HOOLEY | Director | Exer (M) | +158 | — | EDGAR | |
| 2026-05-11 | DANIEL M JUNIUS | Director | Exer (M) | +257 | — | EDGAR | |
| 2026-05-11 | Lawrence D Kingsley | Director | Exer (M) | +339 | — | EDGAR | |
| 2026-05-11 | Karen Peacock | Director | Exer (M) | +101 | — | EDGAR | |
| 2026-05-11 | M ANNE SZOSTAK | Director | Exer (M) | +257 | — | EDGAR |
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | JONATHAN JAY MAZELSKY | President and CEO | 104,556 | $59.33M | -$79.60M | 59 | 2026-03-02 |
| 2 | S SAM FRATONI | Corporate Vice President | 102,312 | $58.06M | -$3.59M | 11 | 2008-10-29 |
| 3 | QUENTIN J TONELLI | Corporate Vice President | 94,332 | $53.53M | -$508.2K | 4 | 2007-05-24 |
| 4 | ROBERT J MURRAY | Director | 79,694 | $45.22M | $987.9K | 29 | 2015-05-08 |
| 5 | ALI NAQUI | Corporate Vice President | 60,948 | $34.58M | -$6.49M | 22 | 2013-05-13 |
| 6 | Michael J PhD Williams | Executive Vice President | 59,113 | $33.54M | -$17.43M | 38 | 2016-08-15 |
| 7 | ROBERT S HULSY | Corporate Vice President | 55,328 | $31.40M | -$7.62M | 6 | 2007-03-20 |
| 8 | Thomas J Dupree | Corporate Vice President | 54,534 | $30.94M | -$6.95M | 7 | 2011-02-22 |
| 9 | BRIAN P MCKEON | EVP, CFO and Treasurer | 49,599 | $28.14M | -$102.93M | 73 | 2025-02-18 |
| 10 | MERILEE RAINES | Executive VP & CFO | 39,332 | $22.32M | -$38.68M | 25 | 2013-02-27 |
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.
Source & freshness: Parsed directly from EDGAR primary-doc XML. Daily refresh; new filings typically appear here the morning after they hit EDGAR.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-05-20 | Margaret Anne Szostak | Director | 1,344 | $744.0K | 2026-05-20 | Goldman Sachs & Co. LLC | — | EDGAR |
| 2026-03-03 | NIMRATA K HUNT | Officer | 1,758 | $1.12M | 2026-03-03 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-02-26 | JONATHAN J MAZELSKY | Officer, Director | 23,326 | $15.34M | 2026-02-26 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-02-25 | NIMRATA K HUNT | Officer | 2,693 | $1.78M | 2026-02-25 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-02-17 | SOPHIE V VANDEBROEK | Director | 1,464 | $920.3K | 2026-02-17 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-02-17 | MICHAEL G ERICKSON | Officer | 5,371 | $3.37M | 2026-02-17 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-02-10 | GEORGE FENNELL | Officer | 11,345 | $7.34M | 2026-02-10 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2025-11-07 | NIMRATA K HUNT | Officer | 9,425 | $6.63M | 2025-11-07 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2025-08-22 | MARGARET ANNE SZOSTAK | Director | 2,187 | $1.42M | 2025-08-22 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2025-08-12 | MICHAEL G ERICKSON | Officer | 407 | $264.5K | 2025-08-12 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-15 | 0000874716-26-000110 | EDGAR |
| 2026-05-05 | 0001104659-26-055203 | EDGAR |
| 2026-03-26 | 0001104659-26-034906 | EDGAR |
| 2026-02-13 | 0000874716-26-000007 | EDGAR |
| 2026-02-02 | 0001104659-26-008904 | EDGAR |
| 2026-01-13 | 0001104659-26-003103 | EDGAR |
| 2025-11-13 | 0001104659-25-111278 | EDGAR |
| 2025-11-03 | 0001104659-25-105185 | EDGAR |
| 2025-10-07 | 0001104659-25-097319 | EDGAR |
| 2025-08-04 | 0001104659-25-073304 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-02-20 | 0000874716-26-000038 | EDGAR |
| 2025-02-21 | 0000874716-25-000037 | EDGAR |
| 2024-02-22 | 0000874716-24-000057 | EDGAR |
| 2023-02-16 | 0000874716-23-000006 | EDGAR |
| 2022-02-16 | 0000874716-22-000007 | EDGAR |
| 2021-02-12 | 0000874716-21-000008 | EDGAR |
| 2020-02-14 | 0000874716-20-000006 | EDGAR |
| 2019-02-15 | 0000874716-19-000004 | EDGAR |
| 2018-02-16 | 0000874716-18-000005 | EDGAR |
| 2017-02-17 | 0000874716-17-000004 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-05 | 0000874716-26-000076 | EDGAR |
| 2025-11-03 | 0000874716-25-000165 | EDGAR |
| 2025-08-04 | 0000874716-25-000121 | EDGAR |
| 2025-05-01 | 0000874716-25-000062 | EDGAR |
| 2024-10-31 | 0000874716-24-000139 | EDGAR |
| 2024-08-06 | 0000874716-24-000121 | EDGAR |
| 2024-05-01 | 0000874716-24-000083 | EDGAR |
| 2023-11-01 | 0000874716-23-000128 | EDGAR |
| 2023-08-01 | 0000874716-23-000100 | EDGAR |
| 2023-05-02 | 0000874716-23-000034 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
| P/E Ratio | 42.2 |
| P/B Ratio | 29.2 |
| P/S Ratio | 10.2 |
| EV/EBITDA | 29.7 |
| TTM Revenue | $4.4B |
| TTM Net Income | $1.1B |
| TTM EPS | $13.59 |
| ROE | 70.4% |
| Debt/Equity | 0.63 |